Tag: CSF
Cerevasc announces positive eShunt study results in elderly NPH patients
Cerevasc has today reported initial results from its pilot US Food and Drug Administration (FDA)-approved investigational device exemption (IDE) clinical study of the eShunt...
Novel EVD catheter scoops US$100,000 SVINnovation prize
A novel catheter intended to improve on the tools currently available in neurosurgical external ventricular drain (EVD) placement was awarded a US$100,000 grand prize...
Nurami receives US FDA 510(k) clearance for resorbable dural repair graft
Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia...
Anuncia announces first successful implant of ReFlow mini flusher in hydrocephalus...
Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device.
Performed on by neurosurgeon Samuel...
Anuncia announces US launch of second-generation ReFlow device to treat hydrocephalus
Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a...
eShunt system offers promise for endovascular treatment of hydrocephalus
“I have tried several devices in the last 10 or 20 years, but I think this is absolutely different—this is the first time that...
ReFlow system mini receives FDA breakthrough device designation
Anuncia has announced that it has received US Food and Drug Administration (FDA) breakthrough device designation for its ReFlow system mini, intended for the treatment of cerebral spinal...
CereVasc gains financing to support eShunt system to treat hydrocephalus
CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of an expanded Series A financing that raised US$43.9 million....
